Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1
- 9 August 2001
- journal article
- review article
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 480-481, 299-304
- https://doi.org/10.1016/s0027-5107(01)00189-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Heterogeneous Nuclear Ribonucleoprotein B1 Expressed in Esophageal Squamous Cell Carcinomas as a New Biomarker for DiagnosisJapanese Journal of Cancer Research, 2000
- Significance of Heterogeneous Nuclear Ribonucleoprotein B1 as a New Early Detection Marker for Oral Squamous Cell CarcinomaJapanese Journal of Cancer Research, 1999
- Mechanistic Aspects of Green Tea as a Cancer Preventive: Effect of Components on Human Stomach Cancer Cell LinesJapanese Journal of Cancer Research, 1999
- Mechanisms of Growth Inhibition of Human Lung Cancer Cell Line, PC‐9, by Tea PolyphenolsJapanese Journal of Cancer Research, 1997
- Clinical development plan: Tea extracts green tea polyphenols epigallocatechin gallateJournal of Cellular Biochemistry, 1996
- Structure and expression of the gene (HNRPA2B1) encoding the human hnRNP protein A2/B1Genomics, 1995
- A Very Low Dose of Green Tea Polyphenols in Drinking Water Prevents N-Methyl-N-nitrosourea-induced Colon Carcinogenesis in F344 RatsJapanese Journal of Cancer Research, 1993
- A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the MouseScience, 1990
- Antitumor promoting activity of (−)‐epigallocatechin gallate, the main constituent of “Tannin” in green teaPhytotherapy Research, 1987
- Combination chemoprevention of cancerNature, 1980